← Back
$GENB All transactions

Generate Biomedicines, Inc.

▲ BUY
9 / 10

Conviction

$ Value

$240K

Shares

20,000

Price

$12

Filed

Mar 6

Why this score? (9/10)
  • Open market buy (+3)
  • C-suite insider (+2)
  • Director (+1)
  • Cluster: 5 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Nally Michael

Title

Chief Executive Officer

CIK

0001763945

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-04

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

572,707

Footnotes

The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Filing Info

Accession No.

0001193125-26-096799

Form Type

4

Issuer CIK

0002100782

Nally Michael's History

Date Ticker Type Value
2026-04-16 PPG A $0
2026-04-15 PPG M $0
2026-04-15 PPG M $199K
2026-03-12 PPG A $7K
2026-03-04 GENB $240K
2026-03-02 GENB C
2026-03-02 GENB C $0
2026-02-26 GENB A $0
2026-02-26 GENB A $0
2025-12-12 PPG A $8K

Other Insiders at GENB (90d)

Insider Bought Sold Last
AFEYAN NOUBAR $150.0M 2026-03-02
Silvers Jason
President & CFO
$32K 2026-03-02
Mendillo Jane L $24K 2026-03-02
Grous Beth
Chief People Officer
$5K 2026-03-02
Fanucci Marsha 2026-02-26
Simonian Nancy A 2026-02-26
Bancel Stephane 2026-03-02
Martin Sean
Chief Legal Officer & GC
2026-02-26
ARNOLD FRANCES 2026-02-26
Vessey Rupert 2026-02-26
Nally Michael
Chief Executive Officer
2026-03-02
Parker Paul Gray 2026-02-26
Grigoryan Gevorg
Chief Technology Officer
2026-02-26
Lee Laurie Anne
Chief Medical Officer
2026-02-26